Please enable JavaScript to continue using this application.

Compare $GERN vs $IMMX | Chartloom

Compare

$GERN vs $IMMX

Geron Corp · Immix Biopharma Inc

GERN

Geron Corp

IMMX

Immix Biopharma Inc

Compare $GERN vs $IMMX

Comparing Geron Corp and Immix Biopharma Inc

GERNGeron Corp

IMMXImmix Biopharma Inc

GERNGeron Corp

Market cap

$786M

P/E (TTM)

—

Forward P/E (NTM)

71.19x

Forward P/S (NTM)

2.69x

Rev growth (TTM)

24.4%

YTD performance

-7.2%

52W performance

-11.2%

FCF yield

-14.6%

IMMXImmix Biopharma Inc

Market cap

$660M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

74.2%

52W performance

272.4%

FCF yield

-5.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GERN

IMMX

Detailed metrics comparison

GERN

Geron Corp

IMMX

Immix Biopharma Inc

Market Cap

GERN$786M

IMMX$660M

Enterprise Value

GERN$973M

IMMX$435M

Price

GERN$1.23

IMMX$9.46

P/E Ratio

GERNN/A

IMMXN/A

P/S Ratio

GERN3.84x

IMMX0.00x

EV/Sales

GERN4.76x

IMMX0.00x

EV/EBITDA

GERN2,038.47x

IMMX0.00x

P/B Ratio

GERN3.53x

IMMX3.03x

P/FCF Ratio

GERNN/A

IMMXN/A

EV/FCF

GERN-8.47x

IMMX-11.12x

PEG Ratio

GERNN/A

IMMXN/A

Forward P/E (NTM)

GERN71.19x

IMMXN/A

Forward P/S (NTM)

GERN2.69x

IMMXN/A

Revenue (TTM)

GERN$205M

IMMX$0

Revenue Growth (YoY)

GERN24.4%

IMMXN/A

Forward Rev Growth

GERN44.7%

IMMX452.1%

Gross Margin (TTM)

GERN96.6%

IMMX0.0%

Operating Margin (TTM)

GERN0.0%

IMMX0.0%

EBITDA Margin (TTM)

GERN-13.9%

IMMX0.0%

Net Margin (TTM)

GERN-33.1%

IMMX0.0%

FCF Margin (TTM)

GERN-56.2%

IMMXN/A

Net Income (TTM)

GERN$-68M

IMMX$-40M

FCF (TTM)

GERN$-115M

IMMX$-39M

EPS (TTM)

GERN-$0.10

IMMX-$0.63

ROE (TTM)

GERN-2932.0%

IMMX-3844.0%

ROA (TTM)

GERN-1234.0%

IMMX-3472.0%

ROIC (TTM)

GERN-1409.0%

IMMX-3844.0%

Cash

GERN$63M

IMMX$225M

Debt

GERN$250M

IMMX$0

Net Cash/Debt

GERN$-187M

IMMX$225M

Current Ratio (TTM)

GERN6.92x

IMMX25.13x

Quick Ratio (TTM)

GERN5.07x

IMMX24.98x

Debt/Equity (TTM)

GERN1.14x

IMMX0.00x

Debt/Assets (TTM)

GERN0.0%

IMMX0.0%

Interest Coverage (TTM)

GERNN/A

IMMXN/A

Net Debt/EBITDA (TTM)

GERN0.00x

IMMX0.00x

Beta

GERN0.57

IMMX0.22

52W Performance

GERN-11.2%

IMMX272.4%

YTD Performance

GERN-7.2%

IMMX74.2%

% from 52W High

GERN-39.1%

IMMX-37.4%

% from 52W Low

GERN17.8%

IMMX309.5%

Asset Turnover (TTM)

GERN0.37x

IMMX0.00x

FCF Yield (TTM)

GERN-14.6%

IMMX-5.9%

Earnings Yield (TTM)

GERN-8.6%

IMMX-6.0%

Dividend Yield (TTM)

GERNN/A

IMMXN/A

Rule of 40

GERN-31.8

IMMX0.0

EV/GP/RG

GERN0.08

IMMXN/A

Ticker research

View GERN research View IMMX research

Metric	GERN Geron Corp	IMMX Immix Biopharma Inc
Market & Valuation
Market Cap	$786M	$660M
Enterprise Value	$973M	$435M
Price	$1.23	$9.46
P/E Ratio	N/A	N/A
P/S Ratio	3.84x	0.00x
EV/Sales	4.76x	0.00x
EV/EBITDA	2,038.47x	0.00x
P/B Ratio	3.53x	3.03x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.47x	-11.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	71.19x	N/A
Forward P/S (NTM)	2.69x	N/A
Revenue & Growth
Revenue (TTM)	$205M	$0
Revenue Growth (YoY)	24.4%	N/A
Forward Rev Growth	44.7%	452.1%
Profitability
Gross Margin (TTM)	96.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-13.9%	0.0%
Net Margin (TTM)	-33.1%	0.0%
FCF Margin (TTM)	-56.2%	N/A
Net Income (TTM)	$-68M	$-40M
FCF (TTM)	$-115M	$-39M
EPS (TTM)	-$0.10	-$0.63
ROE (TTM)	-2932.0%	-3844.0%
ROA (TTM)	-1234.0%	-3472.0%
ROIC (TTM)	-1409.0%	-3844.0%
Financial Health
Cash	$63M	$225M
Debt	$250M	$0
Net Cash/Debt	$-187M	$225M
Current Ratio (TTM)	6.92x	25.13x
Quick Ratio (TTM)	5.07x	24.98x
Debt/Equity (TTM)	1.14x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.57	0.22
52W Performance	-11.2%	272.4%
YTD Performance	-7.2%	74.2%
% from 52W High	-39.1%	-37.4%
% from 52W Low	17.8%	309.5%
Efficiency & Yields
Asset Turnover (TTM)	0.37x	0.00x
FCF Yield (TTM)	-14.6%	-5.9%
Earnings Yield (TTM)	-8.6%	-6.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-31.8	0.0
EV/GP/RG	0.08	N/A
Ticker research	View GERN research	View IMMX research

Valuation

P/S Ratio

IMMX

0.00x

GERN

3.84x

EV/FCF

IMMX

-11.12x

GERN

-8.47x

Growth & revenue

Revenue Growth TTM

GERN

24.4%

Forward Revenue Growth

IMMX

452.1%

GERN

44.7%

Profitability & performance

Gross Margin

GERN

96.6%

IMMX

0.0%

ROE

GERN

-2932.0%

IMMX

-3844.0%

FCF Yield %

IMMX

-5.9%

GERN

-14.6%

52-Week Performance

IMMX

272.4%

GERN

-11.2%

Detailed metrics comparison

GERN

Geron Corp

IMMX

Immix Biopharma Inc

Market Cap

GERN$786M

IMMX$660M

Enterprise Value

GERN$973M

IMMX$435M

Price

GERN$1.23

IMMX$9.46

P/E Ratio

GERNN/A

IMMXN/A

P/S Ratio

GERN3.84x

IMMX0.00x

EV/Sales

GERN4.76x

IMMX0.00x

EV/EBITDA

GERN2,038.47x

IMMX0.00x

P/B Ratio

GERN3.53x

IMMX3.03x

P/FCF Ratio

GERNN/A

IMMXN/A

EV/FCF

GERN-8.47x

IMMX-11.12x

PEG Ratio

GERNN/A

IMMXN/A

Forward P/E (NTM)

GERN71.19x

IMMXN/A

Forward P/S (NTM)

GERN2.69x

IMMXN/A

Revenue (TTM)

GERN$205M

IMMX$0

Revenue Growth (YoY)

GERN24.4%

IMMXN/A

Forward Rev Growth

GERN44.7%

IMMX452.1%

Gross Margin (TTM)

GERN96.6%

IMMX0.0%

Operating Margin (TTM)

GERN0.0%

IMMX0.0%

EBITDA Margin (TTM)

GERN-13.9%

IMMX0.0%

Net Margin (TTM)

GERN-33.1%

IMMX0.0%

FCF Margin (TTM)

GERN-56.2%

IMMXN/A

Net Income (TTM)

GERN$-68M

IMMX$-40M

FCF (TTM)

GERN$-115M

IMMX$-39M

EPS (TTM)

GERN-$0.10

IMMX-$0.63

ROE (TTM)

GERN-2932.0%

IMMX-3844.0%

ROA (TTM)

GERN-1234.0%

IMMX-3472.0%

ROIC (TTM)

GERN-1409.0%

IMMX-3844.0%

Cash

GERN$63M

IMMX$225M

Debt

GERN$250M

IMMX$0

Net Cash/Debt

GERN$-187M

IMMX$225M

Current Ratio (TTM)

GERN6.92x

IMMX25.13x

Quick Ratio (TTM)

GERN5.07x

IMMX24.98x

Debt/Equity (TTM)

GERN1.14x

IMMX0.00x

Debt/Assets (TTM)

GERN0.0%

IMMX0.0%

Interest Coverage (TTM)

GERNN/A

IMMXN/A

Net Debt/EBITDA (TTM)

GERN0.00x

IMMX0.00x

Beta

GERN0.57

IMMX0.22

52W Performance

GERN-11.2%

IMMX272.4%

YTD Performance

GERN-7.2%

IMMX74.2%

% from 52W High

GERN-39.1%

IMMX-37.4%

% from 52W Low

GERN17.8%

IMMX309.5%

Asset Turnover (TTM)

GERN0.37x

IMMX0.00x

FCF Yield (TTM)

GERN-14.6%

IMMX-5.9%

Earnings Yield (TTM)

GERN-8.6%

IMMX-6.0%

Dividend Yield (TTM)

GERNN/A

IMMXN/A

Rule of 40

GERN-31.8

IMMX0.0

EV/GP/RG

GERN0.08

IMMXN/A

Ticker research

View GERN research View IMMX research

Metric	GERN Geron Corp	IMMX Immix Biopharma Inc
Market & Valuation
Market Cap	$786M	$660M
Enterprise Value	$973M	$435M
Price	$1.23	$9.46
P/E Ratio	N/A	N/A
P/S Ratio	3.84x	0.00x
EV/Sales	4.76x	0.00x
EV/EBITDA	2,038.47x	0.00x
P/B Ratio	3.53x	3.03x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.47x	-11.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	71.19x	N/A
Forward P/S (NTM)	2.69x	N/A
Revenue & Growth
Revenue (TTM)	$205M	$0
Revenue Growth (YoY)	24.4%	N/A
Forward Rev Growth	44.7%	452.1%
Profitability
Gross Margin (TTM)	96.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-13.9%	0.0%
Net Margin (TTM)	-33.1%	0.0%
FCF Margin (TTM)	-56.2%	N/A
Net Income (TTM)	$-68M	$-40M
FCF (TTM)	$-115M	$-39M
EPS (TTM)	-$0.10	-$0.63
ROE (TTM)	-2932.0%	-3844.0%
ROA (TTM)	-1234.0%	-3472.0%
ROIC (TTM)	-1409.0%	-3844.0%
Financial Health
Cash	$63M	$225M
Debt	$250M	$0
Net Cash/Debt	$-187M	$225M
Current Ratio (TTM)	6.92x	25.13x
Quick Ratio (TTM)	5.07x	24.98x
Debt/Equity (TTM)	1.14x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.57	0.22
52W Performance	-11.2%	272.4%
YTD Performance	-7.2%	74.2%
% from 52W High	-39.1%	-37.4%
% from 52W Low	17.8%	309.5%
Efficiency & Yields
Asset Turnover (TTM)	0.37x	0.00x
FCF Yield (TTM)	-14.6%	-5.9%
Earnings Yield (TTM)	-8.6%	-6.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-31.8	0.0
EV/GP/RG	0.08	N/A
Ticker research	View GERN research	View IMMX research